PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In summary, genetic factors such as the PNPLA3-I148M variant, alongside epigenetic mechanisms including miR-33 and mitochondrial DNA hypermethylation, drive the metabolic, inflammatory, and fibrotic changes characteristic of MASLD.